Cargando…
Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650
Background: The epithelial layer of the nasal mucosa is the first barrier for drug permeation during intranasal drug delivery. With increasing interest for intranasal pathways, adequate in vitro models are required. Here, porcine olfactory (OEPC) and respiratory (REPC) primary cells were characteris...
Autores principales: | Ladel, Simone, Schlossbauer, Patrick, Flamm, Johannes, Luksch, Harald, Mizaikoff, Boris, Schindowski, Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723747/ https://www.ncbi.nlm.nih.gov/pubmed/31374872 http://dx.doi.org/10.3390/pharmaceutics11080367 |
Ejemplares similares
-
Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells
por: Horváth, Tamás, et al.
Publicado: (2016) -
Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery?
por: Ladel, Simone, et al.
Publicado: (2018) -
Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations
por: Sibinovska, Nadica, et al.
Publicado: (2022) -
Impact of Glycosylation and Species Origin on the Uptake and Permeation of IgGs through the Nasal Airway Mucosa
por: Ladel, Simone, et al.
Publicado: (2020) -
Expression of Estrogen Receptor-alpha in Nasal Polyps and the Effects of Dexamethasone on Estrogen Receptor-alpha Expression in RPMI 2650 Cells
por: Ban, Won Woo, et al.
Publicado: (2020)